Impact of the COVID-19 pandemic on children with psoriasis
- 23 February 2021
- journal article
- research article
- Published by Elsevier BV in Annales de Dermatologie et de Vénéréologie
- Vol. 148 (2), 106-111
- https://doi.org/10.1016/j.annder.2021.01.005
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Coronaviruses and Immunosuppressed Patients: The Facts During the Third EpidemicLiver Transplantation, 2020
- Telehealth transformation: COVID-19 and the rise of virtual careJournal of the American Medical Informatics Association, 2020
- Should biologics for psoriasis be interrupted in the era of COVID-19?Journal of the American Academy of Dermatology, 2020
- Covid-19: risk factors for severe disease and deathBMJ, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- A Novel Coronavirus Emerging in China — Key Questions for Impact AssessmentThe New England Journal of Medicine, 2020
- Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patientsJournal of the American Academy of Dermatology, 2019
- Psoriasis de l’enfant vu en milieu libéral : les aspects cliniques et épidémiologiques diffèrent des données habituellement publiéesAnnales de Dermatologie et de Vénéréologie, 2019
- Psoriasis and obesity in French children: a case-control, multicentre studyBritish Journal of Dermatology, 2014
- Global Epidemiology of Psoriasis: A Systematic Review of Incidence and PrevalenceJournal of Investigative Dermatology, 2013